BioAge Labs, Inc. - Common Stock (BIOA)

BioAge Labs is a biotechnology company focused on leveraging artificial intelligence and machine learning to unlock the biology of aging and develop therapeutics that can extend healthy lifespan

The company harnesses its proprietary platform to analyze vast amounts of biological data in order to identify and validate novel drug targets linked to aging-related diseases. Through its innovative research, BioAge aims to create effective therapies that not only treat age-associated conditions but also improve overall health and longevity in individuals.